Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 3Phase EARLY_PHASE1 2Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

NET 1Lymphoid 1Genitourinary 1Endocrine 1Breast 1

Conditions

Prostatic Neoplasms 1Neuroendocrine Tumors 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Breast Neoplasms 1

Interventions

Cyclophosphamide 416Radiotherapy 276fludarabine 238Gemcitabine 211Cisplatin 203Nivolumab 184pembrolizumab 183Paclitaxel 176Carboplatin 168Magnetic Resonance Spectroscopy 166fludarabine phosphate 156Irinotecan 135Bevacizumab 133Cytarabine 128Capecitabine 124Temozolomide 123Specimen Handling 123Radiosurgery 118Docetaxel 116Biopsy 116Ipilimumab 113Dexamethasone 113Radiation 111Oxaliplatin 110Fluorouracil 110Rituximab 108Etoposide 108Filgrastim 99Lenalidomide 98Everolimus 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × OTHER × Tomography, Emission-Computed, Single-Photon × Clear all
NCT06122610 2026-05-15

Using Novel Imaging to More Safely Treat Neuroendocrine Tumors

University of Wisconsin, Madison

Phase 1 Recruiting
10 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT04746638 2023-11-28

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m RM26

Tomsk National Research Medical Center of the Russian Academy of Sciences

Phase 1 Completed
10 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT04292626 2021-04-01

Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose

Tomsk National Research Medical Center of the Russian Academy of Sciences

Phase 1 Completed
16 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡